Danish pharma giant Novo to use Anthropic’s Claude to advance AI drug discovery
The deal underscores a broader push by drugmakers to integrate AI across research and development to boost new drug discovery.
The deal underscores a broader push by drugmakers to integrate AI across research and development to boost new drug discovery.
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
The deal underscores a broader push by drugmakers to integrate AI across research and development to boost new drug discovery.
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
Anthropic's latest report on the abuse of its AI model found that a Russian-linked hacking group used Claude to automate attacks on more than 20 organisations, including Ukrainian defence ministries and drone…
Sarah Heck, Anthropic's head of public policy, offered her perspectives on AI safety as the debate about how to regulate model development intensifies.
Anthropic’s CEO says he ‘didn’t appreciate’ the speed with which AI’s growth would underpin the global economy.
President Donald Trump has angrily pushed back on the calls from industry and lawmakers for an AI slowdown or greater regulation.
Staff at the Silicon Valley companies are grappling with how to turn AI slowdown rhetoric into reality Grouped from 6 articles across 3 sources.
Anthropic and OpenAI are proposing embedded AI evaluators to help manage risk of models causing catastrophic harm to society, but the idea has some issues.